Skip to main content

Search

Press Releases

Latest News Releases

Nov 01, 2018

United States

Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios

Oct 31, 2018

Ireland

Janssen Reports Positive Topline Results for FLAIR Phase 3 Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1

Oct 30, 2018

United States

U.S. FDA Approves INVOKANA® (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease

Oct 30, 2018

Scotland

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Oct 29, 2018

United States

New Data Presented at Psych Congress 2018 Sheds Light on the Significant Economic Burden of Treatment-Resistant Depression Amongst U.S. Veterans

Oct 26, 2018

United States

Court Issues Ruling in ZYTIGA® Patent Infringement Litigation

Oct 25, 2018

The Netherlands

Johnson & Johnson Unveils New Vaccines Launch Facility to Support Global Rollout of Novel Vaccines

Oct 23, 2018

United States

New Phase 2 Data Show Stelara® (Ustekinumab) Sustained Improvement In Disease Activity In Adults With Systemic Lupus Erythematosus Through One Year

Oct 22, 2018

Spain

Johnson & Johnson Announces Promising, Early-Stage Results for Tetravalent Mosaic-based HIV Preventive Vaccine Regimen

Oct 19, 2018

United States

Janssen Announces New Three-Year TREMFYA (Guselkumab) Data Demonstrates Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis